Membrane mesothelin expression positivity is associated with poor clinical outcome of luminal-type breast cancer.
Suzuki T, Yamagishi Y, Einama T, Koiwai T, Yamasaki T, Fukumura-Koga M, Ishibashi Y, Takihata Y, Shiraishi T, Miyata Y, Iwasaki T, Shinto E, Sato K, Ueno H, Yamamoto J, Kishi Y, Tsuda H.
Suzuki T, et al. Among authors: iwasaki t.
Oncol Lett. 2020 Nov;20(5):193. doi: 10.3892/ol.2020.12055. Epub 2020 Sep 3.
Oncol Lett. 2020.
PMID: 32952662
Free PMC article.